Antibacterial Activity of Phytochemicals in Ficus thonningii Leaves Extracts Against Some Selected Pathogenic Bacterial Prevalent in Sickle Cell Anemia
DOI:
https://doi.org/10.35516/jjps.v16i2.344Keywords:
Antibacterial, Ficus thonningii, infections, sickle cell anemia, ethnomedicineAbstract
Sickle cell anemia (SCA) is caused by point mutation involving substitution of valine by glutamic acid, clinical cause of this is that SCA patients are immunocompromised hence, prone to bacterial infections. Escherichia coli, Klebsiella. pneumoniae, Salmonella typhi, Streptococcus pneumoniae and Staphylococcus aureus are some of the bacterial associated with SCA. Here we investigated the antibacterial activity of extracts of Ficus thonningii leaves used by ethnomedicinal practitioners in the management of infections in SCA patients. The antimicrobial activity was determined based on average diameter of zone of inhibition (AVDZI), minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) while, structure of compounds FTH1 (Bergapten), FTH2 (Protocatechuic acid) and FTH3 (Methyl ferulate) were identified based on Nuclear Magnetic Resonance (NMR) analysis. The results indicated that the crude extracts of methanol (MCE), hexane (HCE), chloroform (CCE) and methanol-water (MWCE) had AVDZI of ≥ 12.1 ± 0.12 mm, ≥ 11.0 ± 0.00 mm, ≥ 10.2 ± 0.25 mm and ≥ 12.1 ± 0.21 mm respectively while the isolated compounds FTH1, FTH2 and FTH3 had AVDZI of ≥ 10.1 ± 0.10 mm, ≥ 9.1 ± 0.12 mm, ≥ 7.1 ± 0.24 mm respectively. The AVDZI results was tested for statistical significance using one way ANOVA and Tukey Posthoc test, and was considered significant at p < 0.05. Our findings suggested that F. thonningii leaves extracts including compounds isolated from them are potential antibacterial agent and justify their use as antibacterial prophylactics in the management of infections in SCA patients by ethnic people in Nigeria
References
Booth C., Inusa B. and Obaro S. K. Infection in sickle cell disease: A review. Int. J. Infect. Dis. 2010; 14(1):e2-e12.
Atkins B. L., Price E. H., Tillyer L., Novelli V. and Evans J. Salmonella osteomyelitis in sickle cell disease children in the East End of London. J. Infect. 1997; 34(2):133-138
Win N. Blood transfusion therapy for haemoglobinopathies; In: Okpala I, editor. Practical management of haemoglobinopathies. Blackwell Publishing limited, New Jersey. 2004, pp99-106.
Vichinsky E. P., Neumayr L. D., Earles A. N., Williams R., Lennette E. T., Dean D., Nickerson B., Orringer E., Mckie V., Bellevue R., Daeschner C., Abboud M., Moncino M., Ballas S., Ware R. and Manci E. A. Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N. Engl. J. Med. 2000; 342(25): 1855—1865.
Stuart M. J. and Nigel R. L. “Sickle-cell disease,” Lancet. 2004; 364(9442): 1343—1360.
Neumayr L., Lennette E., Kelly D., Earles A., Embury S., Groncy P., Grossi M., Grover R., Mcmahon L., Swerdlow P., Waldron P. and Vichinsky E. Mycoplasma disease and acute chest syndrome in sickle cell disease. Pediatr. 2003; 112(1): pt1, 87-95.
Frenette P. S. and Atweh G. F. Sickle cell disease: old discoveries, new concepts and future promise. J. Clin. Investig. 2007; 117: 850-858.
Dick M. Sickle cell disease in childhood. Standards and guidelines for clinical care. NHS Sickle cell and thalassemia screening programme. 2010, pp1-53
Hirst C. and Owusu-Ofori S. Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease. Cochrane Database Syst Rev., 2002; 3: CD003427
Reynolds R., Potz N., Colman M., Williams A., Livermore D. and MacGowan A. BSAC Extended Working Party on Bacteremia Resistance Surveillance. Antimicrobial sensitivity of the pathogens of bacteremia in the UK and Ireland 2001-2: the BSAC Bacteremia Resistance Surveillance Programme. J. Antimicrob. Chemother. 2004; 53:1018—1032.
Ochocinski D., Dalal M., Black V. L., Carr S., Lew J., Sullivan K. and Kissoon N. Life threatening Infectious Complications in Sickle cell Disease: A concise Narrative Review. Front Pediatr. 2020; 8(38): 1-22
Roskov Y., Ower G., Orrell T., Nicolson D., Bailly N., Kirk P. M., Bourgoin T., Dewalt R. E., Decock W., Nieukerken E. and Penev L. Specie 2000. Naturalis, Leiden, the Netherland, 2020.
Global Biodiversity Information Facility Secretariat. Ficus thonningii Blume. GBIF Backbone Taxonomy. Checklist dataset, 2019. [online]. Available: https://hosted-datasets.gbif.org/datasets/backbone/
Harborne J. B. Phytochemical Methods- A guide to modern Techniques of plant analysis. 3rd edition, Chapman and Hall, London, 1988, pp.1-230.
Adeniyi B. A., Odelola H. A. and Oso B. A. Antimicrobial potential of Diospyros mesiliforus (Ebenaceae). Afr. J. Med. Med Sci. 1996; 25(3):221-224.
Cheesbrough M. Antimicrobial susceptibility testing. District Laboratory Practice in tropical countries part 2, 2nd edition, Cambridge University press, United Kingdom, 2000, pp. 132-143.
Esimone C. O., Adikwu M. U. and Okonta J. M. Preliminary antimicrobial screening of ethanolic extract from the lichen Usnea subfloridans (L). J. Pharm. Res. Dev. 1998; 3(2): 99-101.
Adebayo E. A., Ishola O. R., Taiwo O. S., Majolagbe O. N. and Adekeye B. T. Evaluations of the methanol extract of Ficus exasperata stem bark, leaf and root for phytochemical analysis and antimicrobial activities. Afr. J. Plant Sci. 2009; 3(12): 283-287.
Chavan M. C., Navratne A. R., Patil R. B., Vanjari S. S. and Khandelwal K. R. Development and validation of stability indicating high performance thin layer chromatography method for analysis of Bergapten. J. Pharm. Sci. Res. 2019; 11(9):3237-3242.
Chunyan C., Bo S., Ping L., Jingmei L. and Ito Y. Isolation and purification of psoralen and bergapten from Ficus carica l leaves by high-speed countercurrent chromatography. J. Liq. Chromatogr. Relat. Technol. 2009; 32(1):136–143
Liu R., Feng L., Sun A. and Kong L. Preparative isolation and purification of coumarins from Cnidium monnieri (L.) Cusson by high-speed counter-current chromatography. J. Chromatogr. A. 2004; 20014(1005): 71–76.
Sahil K. and Souravh B. A. Review of protocatechuic acid and its pharmacological potential. Int. Sch. Res. Notices. 2014; 12(952943).
Benahmed M., Akkal S., Elomri A., Laouer H., Verite P. and Seguin E. Constituents from Bulpleurum montanum (Coss and Dur) (Apiaceae). Arabian J. Chem. 2011; 1-5.
Ijoma K. I. and Ajiwe V. I. E. Methyl ferulate induced conformational changes on DeOxyHbS: Implication on sickle erythrocyte polymerization. Mediterr. J. Chem. 2022; 12(1):100-111
Madeiro A. L., Borges H. P. B., Souto A. L., Figueiredo T. R., Siqueira-Junior J. P. and Tavares J. F. Modulation of the antibiotic activity against multidrug resistant strains of coumarins isolated from Rutaceae species. Microb. pathog. 2017; 104:151-154
Quetglas-Llabres M. M., Quipe C., Herrera-Bravo J., Catarino M. D., Pereira O. R., Cardoso S. M., Dua K., Chellappan D. K., Pabreja K., Satija S., Mehta M., Sureda A., Martorell M., Satmbekova D., Yeskaliyeva B., Sharifi-Rad J., Rasool N., Butnariu M., Bagiu C. J, Bagiu R. V, Calina D. and Cho W. C. Pharmacological properties of bergapten: mechanistic and therapeutic aspects. Oxid. Med. Cell. Longev. 2022; 8615242: 1-10.
Semaming Y., Pannengpetch P., Chattipakorn S. C. and Chattipakorn N. Pharmacological properties of protocatechuic acid and its potential roles as complementary medicine. Evid-Based. Complement. Altern. Med. 2015; 593902: 1-11.
Li T., Shen Y., Chen H., Xu Y., Wang D., Cui F., Han Y. and Li J. Antimicrobial properties of coaxial spinning membrane of methyl ferulate/zein and its preservation effects on Sea Bass. Foods. 2021; 10(10): 2385, 1-15.
Wang W., Sun Q., Gan N., Zhai Y., Xiang H. and Li H. Characterizing the interaction between methyl Ferulate and human serum albumin by saturation transfer difference NMR. RSC. Adv. 2020; 10(54): 32999-33009.
Ijoma K. I. and Ajiwe V. I. E. Jatropha tanjorensis a flora of Southeast Nigeria: Isolation and Characterization of naringenin and validation of bio-enhanced synergistical activity of α-tocopherol toward clinical isolates of resistant bacterial. Makara J. Sci. 2022; 26(2): 120-127
Dangarembizi R., Erlwanger K. H., Moyo D. and Chivandi E. Phytochemistry, Pharmacology and Ethnomedicinal uses of Ficus thonningii (blume moraceae): A Review. Afr. J. Tradit. Complement. Altern. Med. 2013; 10(2): 203-212
Cousins O. N. and Michael A. H. Medicinal properties in the diet of Gorillas. An ethno-pharmacological evaluation,” Afr. Study Monogr. 2002; 23(2): 65-89
Barret-Connor E. Bacterial infection and sickle cell anaemia. Medicine (Baltimore). 1971; 50(2): 97-112.
Powars D., Overturf G. and Turner E. Is there an increased risk of Haemophilus influenzae septicemia in children with sickle cell anemia? Pediatr. 1983; 71(6): 927–931
Wright J., Thomas P. and Serjeant G. R. Septicemia caused by salmonella infection: an overlooked complication of sickle cell disease. J. Pediatr. 1997; 130(3): 394–399.
Amyes S. Antimicrobial chemotherapy: Pocketbook. Chemical Rubber Company Press, Florida, USA, 1996, p25
French G. L. Bactericidal agents in the treatment of MRSA infections-the potential role of daptomycin. J. Antimicrob. Chemother. 2006; 58(6): 1107-1117
Alima Yanda A. N, Nansseu J. R., Awa H. D., Tatah S. A., Seungue J., Eposse C. and Koki P. O. Burden and spectrum of bacterial infections among sickle cell disease children living in Cameroon. BMC. Infect. Dis. 2017; 17(21): 1-7.
Sowndhariya, S., Ravi, S., Dharani, J. and Sripathi, R. Chemical constitution, in silico molecular docking studies and antibacterial activity of flower essential oil of Artabotrys hexapetalus. Jordan J. Pharm. Sci. 2022; 15(3):341-354.
Mbang, N.F., Olutayo, A.A., Lateef, G.B., Oluyemisi, A.B., Florence, O.O., Olufunke, C.B. and Khalidat, O.O. Evaluation of the antimicrobial activity of Strombosia grandifolia Hook f.ex Benth extract hand sanitizer formulation. Jordan J. Pharm. Sci. 16(1):61-71.
